Clinical Trials Directory

Trials / Terminated

TerminatedNCT01656434

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

A Phase III, Randomized, Open-label, Active-controlled, Multicenter Trial to Study the Contraceptive Efficacy and Safety of the Commercial Batch of Oral Tablets of MK-8175A (Nomegestrol Acetate - 17ß-estradiol) in Healthy, Sexually-active Women Aged 18-50 Years

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
3,173 (actual)
Sponsor
Organon and Co · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to assess the contraceptive efficacy of a nomegestrol acetate + 17ß-estradiol (NOMAC-E2) combined oral contraceptive (COC) in healthy, sexually-active American women at risk for pregnancy. Vaginal bleeding patterns of women taking NOMAC-E2 were assessed and compared to those of women taking a norethisterone acetate + ethinyl estradiol (NETA-EE) COC. The safety of NOMAC-E2 was also assessed. Participants were randomized to receive either NOMAC-E2 or NETA-EE in a 3:1 ratio. As of Amendment 1 (which increased the sample size of the NOMAC-E2 group), the randomization ratio was adapted accordingly for participants randomized after the sample size increase.

Detailed description

This study was terminated early. The decision to terminate the study was based upon difficulties encountered with data collection (related to incomplete e-Diary entries) in concert with business considerations. The decision was not related to any new or unexpected safety or efficacy findings with NOMAC-E2. As a result of this early termination, none of the pre-specified efficacy endpoints were analyzed.

Conditions

Interventions

TypeNameDescription
DRUGNOMAC-E2NOMAC-E2 film-coated oral tablets containing 2.5 mg nomegestrol acetate and 1.5 mg 17ß-estradiol.
DRUGNETA-EENETA-EE film-coated oral tablets containing 1 mg norethisterone acetate and 10 μg ethinylestradiol.
OTHERPlacebotablet
DRUGethinylestradiol (EE)EE 10 μg tablet
DRUGferrous fumarateferrous fumarate 75 mg tablet

Timeline

Start date
2012-11-02
Primary completion
2014-02-12
Completion
2014-02-12
First posted
2012-08-03
Last updated
2024-06-20
Results posted
2015-03-17

Source: ClinicalTrials.gov record NCT01656434. Inclusion in this directory is not an endorsement.